Galecto Biotech
PublicLast Round
Private Placement
Nov 10, 2025
Total Funding Raised
$527.9M
Company Overview
Galecto (NAS: GLTO) is a biotechnology company focused on developing therapeutics that target the biological processes underlying fibrosis and related diseases, including cancer.
Sector
Healthcare
AI Layer
Non-AI
Keywords
small molecule therapeutics for cancer and fibrosisgalectin-3 inhibitor developmentclinical-stage drug developmentdual ENL-YEATS and FLT3 inhibitoracute myeloid leukemia (AML) therapeuticsLOXL2 inhibitor for myelofibrosistherapeutics for liver cirrhosisoncology small molecule drug pipelinefibrotic disease drug discoverypharmaceutical licensing and partnership modeloral small molecule drug candidateinhaled galectin-3 inhibitor
Galecto Biotech Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Galecto Biotech Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Private Placement | Nov 10, 2025 | ||||
| IPO Announced | Oct 28, 2020 | ||||
| Series D | Sep 25, 2020 | ||||
| Series C | Oct 26, 2018 | ||||
| Series A | Oct 30, 2013 |
Galecto Biotech Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Andreessen Horowitz | Private Placement |
| Heartcore Capital | Seed, Series A, Series C, Series D |
| Soleus Capital | Series D |
| Janus Henderson Group | Series D, Private Placement |
| Balyasny Asset Management L.P. | Private Placement |
| RA Capital Management | Private Placement |
| TCG Crossover | Private Placement |
Galecto Biotech Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Firmographic Details
HeadquartersCopenhagen, Capital Region of Denmark
Employee Range11
Year Founded2010
Last FundingNov 10, 2025